These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38100078)

  • 1. Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye.
    Qin G; Chen J; Li L; Qi Y; Chen Y; Zhang Q; Wu Y; You Y; Yang L; Guo N; Moutari S; Bu S; Moore JE; Xu L; He W; Yu S; He X; Pazo EE
    J Ocul Pharmacol Ther; 2024; 40(6):370-378. PubMed ID: 38100078
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
    Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerability of Diquas LX on tear film and meibomian glands findings in a real clinical scenario.
    Arita R; Fukuoka S; Kaido M
    PLoS One; 2024; 19(9):e0305020. PubMed ID: 39325761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
    Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
    Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
    Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
    Utsunomiya T; Kawahara A; Hanada K; Yoshida A
    Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
    Koh S; Ikeda C; Takai Y; Watanabe H; Maeda N; Nishida K
    Jpn J Ophthalmol; 2013 Sep; 57(5):440-6. PubMed ID: 23740285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease.
    Chen J; Chen Y; Qin G; Li L; Li M; Cheng Y; Zhuang S; Li Z; Zhang Q; Wu Y; Yang L; Moutari S; Moore JE; Xu L; He W; Yu S; Pazo EE; He X
    Trials; 2023 Dec; 24(1):803. PubMed ID: 38087329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
    Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC
    Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Controlled Study to Investigate the Effect of Topical Diquafosol Tetrasodium on Corneal Sensitivity in Short Tear Break-Up Time Dry Eye.
    Kaido M; Kawashima M; Shigeno Y; Yamada Y; Tsubota K
    Adv Ther; 2018 May; 35(5):697-706. PubMed ID: 29671255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Diquafosol Ophthalmic Solution on Clinical Parameters and Visual Function in Soft Contact Lens-Related Dry Eye.
    Ogami T; Asano H; Hiraoka T; Yamada Y; Oshika T
    Adv Ther; 2021 Nov; 38(11):5534-5547. PubMed ID: 34590267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trial.
    Jin Y; Seo KY; Kim SW
    Sci Rep; 2024 Jun; 14(1):13306. PubMed ID: 38858411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
    Jeon HS; Hyon JY
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a Long-Acting Diquafosol Ophthalmic Solution on the Ocular Surface, Tolerability, and Usability in Dry Eye Disease.
    Kaido M; Arita R
    Adv Ther; 2024 Jun; 41(6):2477-2485. PubMed ID: 38709396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study.
    Chen J; Qin G; Li L; Qi Y; Xia Y; Zhang Q; Wu Y; You Y; Yang L; Guo N; Moutari S; Moore JE; Bu S; Xu L; He W; Yu S; Pazo EE; He X
    Ophthalmol Ther; 2023 Dec; 12(6):2959-2971. PubMed ID: 37589932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diquafosol ophthalmic solution for dry eye treatment.
    Nakamura M; Imanaka T; Sakamoto A
    Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Topical Cyclosporine and Diquafosol Treatment in Dry Eye.
    Yang JM; Choi W; Kim N; Yoon KC
    Optom Vis Sci; 2015 Sep; 92(9):e296-302. PubMed ID: 26107023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
    Mun Y; Kwon JW; Oh JY
    BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.